CS
BBH icon

Comerica Securities’s VanEck Biotech ETF BBH Stock Holding History

Comerica Securities’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$486K Hold
3,120
– – 0.04% 277
2023
Q2 		$487K Sell
3,120
-17
-0.5% -$2.72K 0.03% 305
2023
Q1 		$508K Buy
3,137
+1,389
+79% +$225K 0.04% 296
2022
Q4 		$279K Buy
+1,748
New +$277K 0.02% 397

Other funds holding BBH

MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CIG
Consolidated Investment Group Englewood, Colorado $922M AUM 28.87% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Comerica Securities's BBH Position: Q3 2023 in Review

Comerica Securities held its VanEck Biotech ETF (BBH) position steady in Q3 2023 at 3,120 shares worth $486K. The position accounts for 0.04% of the portfolio, ranked #277.

Comerica Securities first reported a position in BBH in Q4 2022 and has held it in 4 quarters since. The position peaked at $508K in Q1 2023. 110 funds tracked by Wall St. Rank hold BBH as of Q3 2023.

  • Comerica Securities held 3,120 shares of VanEck Biotech ETF worth $486K as of Q3 2023.
  • Comerica Securities left its VanEck Biotech ETF share count unchanged in Q3 2023.
  • VanEck Biotech ETF made up 0.04% of Comerica Securities's portfolio in Q3 2023, its #277 holding.
  • Comerica Securities first reported a position in VanEck Biotech ETF in Q4 2022 and has held it in 4 quarters since.
  • Comerica Securities's VanEck Biotech ETF position peaked at $508K in Q1 2023.
  • 110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2023.

Based on Comerica Securities's 13F filing for Q3 2023, filed 26 Oct 2023.